nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—UGT1A1—Indacaterol—asthma	0.0591	0.126	CbGbCtD
Nilotinib—ABCG2—Zafirlukast—asthma	0.0237	0.0505	CbGbCtD
Nilotinib—CYP2C8—Mometasone—asthma	0.0161	0.0343	CbGbCtD
Nilotinib—CYP2C8—Salmeterol—asthma	0.0161	0.0343	CbGbCtD
Nilotinib—ABCB1—Fluticasone furoate—asthma	0.0144	0.0306	CbGbCtD
Nilotinib—CYP2C8—Zafirlukast—asthma	0.0126	0.0269	CbGbCtD
Nilotinib—ABCB1—Indacaterol—asthma	0.0117	0.025	CbGbCtD
Nilotinib—CYP2D6—Ciclesonide—asthma	0.011	0.0235	CbGbCtD
Nilotinib—CYP2C9—Zileuton—asthma	0.01	0.0213	CbGbCtD
Nilotinib—CYP2C8—Theophylline—asthma	0.00976	0.0208	CbGbCtD
Nilotinib—ABCG2—Hydrocortisone—asthma	0.00966	0.0206	CbGbCtD
Nilotinib—CYP2C8—Loratadine—asthma	0.00925	0.0197	CbGbCtD
Nilotinib—CYP2C8—Montelukast—asthma	0.00925	0.0197	CbGbCtD
Nilotinib—CYP2D6—Ipratropium bromide—asthma	0.00915	0.0195	CbGbCtD
Nilotinib—CYP2C9—Zafirlukast—asthma	0.00881	0.0188	CbGbCtD
Nilotinib—CYP3A4—Fluticasone furoate—asthma	0.00862	0.0183	CbGbCtD
Nilotinib—CYP2C9—Formoterol—asthma	0.00851	0.0181	CbGbCtD
Nilotinib—CYP2C9—Arformoterol—asthma	0.00851	0.0181	CbGbCtD
Nilotinib—CYP2D6—Zafirlukast—asthma	0.00806	0.0172	CbGbCtD
Nilotinib—CYP2D6—Formoterol—asthma	0.00778	0.0166	CbGbCtD
Nilotinib—CYP2D6—Arformoterol—asthma	0.00778	0.0166	CbGbCtD
Nilotinib—CYP3A4—Budesonide—asthma	0.00768	0.0163	CbGbCtD
Nilotinib—CYP3A4—Ciclesonide—asthma	0.00702	0.0149	CbGbCtD
Nilotinib—CYP3A4—Indacaterol—asthma	0.00702	0.0149	CbGbCtD
Nilotinib—CYP2D6—Tiotropium—asthma	0.00694	0.0148	CbGbCtD
Nilotinib—CYP2C9—Theophylline—asthma	0.0068	0.0145	CbGbCtD
Nilotinib—CYP3A4—Salmeterol—asthma	0.00653	0.0139	CbGbCtD
Nilotinib—CYP3A4—Flunisolide—asthma	0.00653	0.0139	CbGbCtD
Nilotinib—CYP3A4—Salbutamol—asthma	0.00653	0.0139	CbGbCtD
Nilotinib—CYP2C9—Montelukast—asthma	0.00645	0.0137	CbGbCtD
Nilotinib—CYP2C9—Loratadine—asthma	0.00645	0.0137	CbGbCtD
Nilotinib—ABCB1—Loratadine—asthma	0.00626	0.0133	CbGbCtD
Nilotinib—CYP2D6—Theophylline—asthma	0.00622	0.0132	CbGbCtD
Nilotinib—ABCG2—Dexamethasone—asthma	0.00601	0.0128	CbGbCtD
Nilotinib—CYP2D6—Loratadine—asthma	0.0059	0.0126	CbGbCtD
Nilotinib—CYP3A4—Ipratropium bromide—asthma	0.00582	0.0124	CbGbCtD
Nilotinib—CYP3A4—Zileuton—asthma	0.00582	0.0124	CbGbCtD
Nilotinib—ABCB1—Methylprednisolone—asthma	0.00573	0.0122	CbGbCtD
Nilotinib—CYP3A4—Fluticasone Propionate—asthma	0.00555	0.0118	CbGbCtD
Nilotinib—CYP2C8—Hydrocortisone—asthma	0.00514	0.0109	CbGbCtD
Nilotinib—CYP3A4—Zafirlukast—asthma	0.00512	0.0109	CbGbCtD
Nilotinib—CYP3A4—Tiotropium—asthma	0.00441	0.00939	CbGbCtD
Nilotinib—CYP2B6—Dexamethasone—asthma	0.00422	0.00899	CbGbCtD
Nilotinib—CYP3A4—Aminophylline—asthma	0.00421	0.00896	CbGbCtD
Nilotinib—CYP3A4—Theophylline—asthma	0.00396	0.00842	CbGbCtD
Nilotinib—CYP3A4—Loratadine—asthma	0.00375	0.00798	CbGbCtD
Nilotinib—CYP3A4—Montelukast—asthma	0.00375	0.00798	CbGbCtD
Nilotinib—ABCB1—Betamethasone—asthma	0.00372	0.00792	CbGbCtD
Nilotinib—ABCB1—Prednisolone—asthma	0.00367	0.00782	CbGbCtD
Nilotinib—CA6—saliva—asthma	0.00353	0.0336	CbGeAlD
Nilotinib—ABCB1—Hydrocortisone—asthma	0.00348	0.00741	CbGbCtD
Nilotinib—ABCB1—Prednisone—asthma	0.00347	0.00738	CbGbCtD
Nilotinib—CYP3A4—Methylprednisolone—asthma	0.00343	0.0073	CbGbCtD
Nilotinib—CYP2C8—Dexamethasone—asthma	0.0032	0.00681	CbGbCtD
Nilotinib—CYP3A4—Triamcinolone—asthma	0.0026	0.00553	CbGbCtD
Nilotinib—MAPK8—exocrine gland—asthma	0.00248	0.0237	CbGeAlD
Nilotinib—CYP2C9—Dexamethasone—asthma	0.00223	0.00475	CbGbCtD
Nilotinib—CYP3A4—Betamethasone—asthma	0.00223	0.00475	CbGbCtD
Nilotinib—CYP3A4—Prednisolone—asthma	0.0022	0.00468	CbGbCtD
Nilotinib—ABCB1—Dexamethasone—asthma	0.00217	0.00461	CbGbCtD
Nilotinib—CYP3A4—Hydrocortisone—asthma	0.00209	0.00444	CbGbCtD
Nilotinib—CYP3A4—Prednisone—asthma	0.00208	0.00442	CbGbCtD
Nilotinib—CYP2D6—Dexamethasone—asthma	0.00204	0.00434	CbGbCtD
Nilotinib—Imatinib—NTRK1—asthma	0.00204	0.872	CrCbGaD
Nilotinib—CA6—exocrine gland—asthma	0.00178	0.017	CbGeAlD
Nilotinib—CDC42BPB—respiratory system—asthma	0.00143	0.0136	CbGeAlD
Nilotinib—CYP3A4—Dexamethasone—asthma	0.0013	0.00276	CbGbCtD
Nilotinib—MAPK8—respiratory system—asthma	0.00129	0.0123	CbGeAlD
Nilotinib—CDC42BPB—adrenal cortex—asthma	0.0012	0.0114	CbGeAlD
Nilotinib—CDC42BPB—bronchus—asthma	0.00118	0.0112	CbGeAlD
Nilotinib—CDC42BPB—smooth muscle tissue—asthma	0.00115	0.011	CbGeAlD
Nilotinib—TIE1—respiratory system—asthma	0.00112	0.0107	CbGeAlD
Nilotinib—CDC42BPB—cardiovascular system—asthma	0.00109	0.0104	CbGeAlD
Nilotinib—MAPK8—epithelium—asthma	0.00108	0.0103	CbGeAlD
Nilotinib—MAPK8—bronchus—asthma	0.00106	0.0101	CbGeAlD
Nilotinib—CDC42BPB—trachea—asthma	0.00106	0.0101	CbGeAlD
Nilotinib—MAPK8—smooth muscle tissue—asthma	0.00104	0.00993	CbGeAlD
Nilotinib—KIT—exocrine gland—asthma	0.00104	0.00988	CbGeAlD
Nilotinib—BLK—adrenal gland—asthma	0.00099	0.00945	CbGeAlD
Nilotinib—MAPK8—cardiovascular system—asthma	0.00099	0.00944	CbGeAlD
Nilotinib—MAP4K1—bronchus—asthma	0.000967	0.00922	CbGeAlD
Nilotinib—TIE1—adrenal cortex—asthma	0.00094	0.00897	CbGeAlD
Nilotinib—TIE1—epithelium—asthma	0.000936	0.00893	CbGeAlD
Nilotinib—TIE1—smooth muscle tissue—asthma	0.000902	0.00861	CbGeAlD
Nilotinib—CA3—respiratory system—asthma	0.000879	0.00839	CbGeAlD
Nilotinib—EPHB3—bronchus—asthma	0.000877	0.00837	CbGeAlD
Nilotinib—MAPK11—adrenal gland—asthma	0.000873	0.00833	CbGeAlD
Nilotinib—CDC42BPB—adrenal gland—asthma	0.000866	0.00826	CbGeAlD
Nilotinib—TIE1—cardiovascular system—asthma	0.000858	0.00819	CbGeAlD
Nilotinib—HCK—adrenal cortex—asthma	0.000822	0.00784	CbGeAlD
Nilotinib—MAPK14—respiratory system—asthma	0.000821	0.00783	CbGeAlD
Nilotinib—EPHA3—adrenal gland—asthma	0.000821	0.00783	CbGeAlD
Nilotinib—FGR—respiratory system—asthma	0.000817	0.0078	CbGeAlD
Nilotinib—HCK—bronchus—asthma	0.000806	0.00769	CbGeAlD
Nilotinib—EPHB3—trachea—asthma	0.000788	0.00751	CbGeAlD
Nilotinib—MAPK8—adrenal gland—asthma	0.000783	0.00747	CbGeAlD
Nilotinib—EPHB4—respiratory system—asthma	0.000778	0.00742	CbGeAlD
Nilotinib—EPHA2—respiratory system—asthma	0.000763	0.00728	CbGeAlD
Nilotinib—CDC42BPB—lung—asthma	0.000759	0.00724	CbGeAlD
Nilotinib—TEK—respiratory system—asthma	0.000745	0.0071	CbGeAlD
Nilotinib—EPHA4—bronchus—asthma	0.000733	0.00699	CbGeAlD
Nilotinib—HCK—trachea—asthma	0.000724	0.0069	CbGeAlD
Nilotinib—EPHA3—lung—asthma	0.000719	0.00686	CbGeAlD
Nilotinib—MAP4K1—adrenal gland—asthma	0.000712	0.00679	CbGeAlD
Nilotinib—CA7—trachea—asthma	0.000708	0.00676	CbGeAlD
Nilotinib—MAPK8—lung—asthma	0.000686	0.00655	CbGeAlD
Nilotinib—MAPK14—epithelium—asthma	0.000686	0.00654	CbGeAlD
Nilotinib—TIE1—adrenal gland—asthma	0.000679	0.00648	CbGeAlD
Nilotinib—MAPK14—bronchus—asthma	0.000675	0.00644	CbGeAlD
Nilotinib—PDGFRA—respiratory system—asthma	0.000675	0.00644	CbGeAlD
Nilotinib—CA3—cardiovascular system—asthma	0.000673	0.00642	CbGeAlD
Nilotinib—LCK—bronchus—asthma	0.000673	0.00642	CbGeAlD
Nilotinib—MAPK14—smooth muscle tissue—asthma	0.000661	0.0063	CbGeAlD
Nilotinib—EPHA4—trachea—asthma	0.000658	0.00628	CbGeAlD
Nilotinib—EPHB4—adrenal cortex—asthma	0.000653	0.00623	CbGeAlD
Nilotinib—BRAF—adrenal gland—asthma	0.000651	0.00621	CbGeAlD
Nilotinib—EPHB4—epithelium—asthma	0.00065	0.0062	CbGeAlD
Nilotinib—EPHB3—adrenal gland—asthma	0.000646	0.00616	CbGeAlD
Nilotinib—EPHA2—adrenal cortex—asthma	0.000641	0.00611	CbGeAlD
Nilotinib—EPHB4—bronchus—asthma	0.00064	0.00611	CbGeAlD
Nilotinib—EPHA2—epithelium—asthma	0.000638	0.00608	CbGeAlD
Nilotinib—MAPK14—cardiovascular system—asthma	0.000629	0.006	CbGeAlD
Nilotinib—EPHA2—bronchus—asthma	0.000628	0.00599	CbGeAlD
Nilotinib—EPHB4—smooth muscle tissue—asthma	0.000627	0.00598	CbGeAlD
Nilotinib—FGR—cardiovascular system—asthma	0.000626	0.00597	CbGeAlD
Nilotinib—TEK—adrenal cortex—asthma	0.000625	0.00596	CbGeAlD
Nilotinib—MAP4K1—lung—asthma	0.000624	0.00595	CbGeAlD
Nilotinib—CA12—respiratory system—asthma	0.000623	0.00594	CbGeAlD
Nilotinib—TEK—epithelium—asthma	0.000622	0.00594	CbGeAlD
Nilotinib—CA2—exocrine gland—asthma	0.000614	0.00586	CbGeAlD
Nilotinib—TEK—bronchus—asthma	0.000613	0.00585	CbGeAlD
Nilotinib—LCK—trachea—asthma	0.000604	0.00576	CbGeAlD
Nilotinib—TEK—smooth muscle tissue—asthma	0.0006	0.00572	CbGeAlD
Nilotinib—EPHB4—cardiovascular system—asthma	0.000596	0.00568	CbGeAlD
Nilotinib—TIE1—lung—asthma	0.000595	0.00568	CbGeAlD
Nilotinib—CSF1R—respiratory system—asthma	0.000594	0.00567	CbGeAlD
Nilotinib—HCK—adrenal gland—asthma	0.000593	0.00566	CbGeAlD
Nilotinib—ABL2—adrenal gland—asthma	0.00059	0.00562	CbGeAlD
Nilotinib—EPHB6—bronchus—asthma	0.000586	0.00559	CbGeAlD
Nilotinib—EPHA2—cardiovascular system—asthma	0.000585	0.00558	CbGeAlD
Nilotinib—EPHB4—trachea—asthma	0.000575	0.00548	CbGeAlD
Nilotinib—BRAF—lung—asthma	0.00057	0.00544	CbGeAlD
Nilotinib—TEK—cardiovascular system—asthma	0.00057	0.00544	CbGeAlD
Nilotinib—EPHB3—lung—asthma	0.000566	0.0054	CbGeAlD
Nilotinib—EPHA2—trachea—asthma	0.000564	0.00538	CbGeAlD
Nilotinib—EPHB2—Diflorasone—Fluticasone furoate—asthma	0.000558	0.159	CbGdCrCtD
Nilotinib—PDGFRA—smooth muscle tissue—asthma	0.000543	0.00518	CbGeAlD
Nilotinib—KIT—respiratory system—asthma	0.000539	0.00514	CbGeAlD
Nilotinib—EPHA4—adrenal gland—asthma	0.000539	0.00514	CbGeAlD
Nilotinib—PDGFRB—respiratory system—asthma	0.000527	0.00502	CbGeAlD
Nilotinib—EPHB6—trachea—asthma	0.000526	0.00502	CbGeAlD
Nilotinib—EPHB2—Diflorasone—Fluticasone Propionate—asthma	0.00052	0.149	CbGdCrCtD
Nilotinib—HCK—lung—asthma	0.00052	0.00496	CbGeAlD
Nilotinib—ABL2—lung—asthma	0.000517	0.00493	CbGeAlD
Nilotinib—PDGFRA—cardiovascular system—asthma	0.000517	0.00493	CbGeAlD
Nilotinib—MAP2K5—adrenal cortex—asthma	0.000511	0.00487	CbGeAlD
Nilotinib—MAP2K5—bronchus—asthma	0.000501	0.00478	CbGeAlD
Nilotinib—PDGFRA—trachea—asthma	0.000499	0.00476	CbGeAlD
Nilotinib—CSF1R—adrenal cortex—asthma	0.000498	0.00475	CbGeAlD
Nilotinib—MAPK14—adrenal gland—asthma	0.000497	0.00474	CbGeAlD
Nilotinib—LCK—adrenal gland—asthma	0.000495	0.00472	CbGeAlD
Nilotinib—FGR—adrenal gland—asthma	0.000495	0.00472	CbGeAlD
Nilotinib—CA1—respiratory system—asthma	0.000493	0.00471	CbGeAlD
Nilotinib—CSF1R—bronchus—asthma	0.000489	0.00466	CbGeAlD
Nilotinib—CA14—adrenal gland—asthma	0.000484	0.00461	CbGeAlD
Nilotinib—CSF1R—smooth muscle tissue—asthma	0.000478	0.00456	CbGeAlD
Nilotinib—EPHA4—lung—asthma	0.000473	0.00451	CbGeAlD
Nilotinib—EPHB4—adrenal gland—asthma	0.000471	0.0045	CbGeAlD
Nilotinib—ABL1—respiratory system—asthma	0.000469	0.00448	CbGeAlD
Nilotinib—CA3—lung—asthma	0.000467	0.00445	CbGeAlD
Nilotinib—MAP2K5—cardiovascular system—asthma	0.000466	0.00445	CbGeAlD
Nilotinib—EPHA2—adrenal gland—asthma	0.000462	0.00441	CbGeAlD
Nilotinib—CA12—trachea—asthma	0.00046	0.00439	CbGeAlD
Nilotinib—CSF1R—cardiovascular system—asthma	0.000455	0.00434	CbGeAlD
Nilotinib—TEK—adrenal gland—asthma	0.000451	0.0043	CbGeAlD
Nilotinib—KIT—epithelium—asthma	0.000451	0.0043	CbGeAlD
Nilotinib—MAP2K5—trachea—asthma	0.00045	0.00429	CbGeAlD
Nilotinib—KIT—bronchus—asthma	0.000444	0.00423	CbGeAlD
Nilotinib—PDGFRB—adrenal cortex—asthma	0.000442	0.00422	CbGeAlD
Nilotinib—PDGFRB—epithelium—asthma	0.00044	0.0042	CbGeAlD
Nilotinib—CSF1R—trachea—asthma	0.000439	0.00419	CbGeAlD
Nilotinib—MAPK14—lung—asthma	0.000436	0.00416	CbGeAlD
Nilotinib—KIT—smooth muscle tissue—asthma	0.000434	0.00414	CbGeAlD
Nilotinib—LCK—lung—asthma	0.000434	0.00414	CbGeAlD
Nilotinib—FGR—lung—asthma	0.000434	0.00414	CbGeAlD
Nilotinib—PDGFRB—bronchus—asthma	0.000434	0.00414	CbGeAlD
Nilotinib—EPHB6—adrenal gland—asthma	0.000431	0.00411	CbGeAlD
Nilotinib—PDGFRB—smooth muscle tissue—asthma	0.000424	0.00405	CbGeAlD
Nilotinib—EPHB4—lung—asthma	0.000413	0.00394	CbGeAlD
Nilotinib—KIT—cardiovascular system—asthma	0.000413	0.00394	CbGeAlD
Nilotinib—PDGFRA—adrenal gland—asthma	0.000409	0.0039	CbGeAlD
Nilotinib—EPHA2—lung—asthma	0.000405	0.00387	CbGeAlD
Nilotinib—PDGFRB—cardiovascular system—asthma	0.000403	0.00385	CbGeAlD
Nilotinib—KIT—trachea—asthma	0.000399	0.0038	CbGeAlD
Nilotinib—TEK—lung—asthma	0.000395	0.00377	CbGeAlD
Nilotinib—ABL1—adrenal cortex—asthma	0.000394	0.00376	CbGeAlD
Nilotinib—PDGFRB—trachea—asthma	0.000389	0.00371	CbGeAlD
Nilotinib—ABL1—bronchus—asthma	0.000386	0.00369	CbGeAlD
Nilotinib—CA4—respiratory system—asthma	0.000386	0.00368	CbGeAlD
Nilotinib—EPHB2—Diflorasone—Beclomethasone—asthma	0.000382	0.109	CbGdCrCtD
Nilotinib—ABL1—smooth muscle tissue—asthma	0.000378	0.00361	CbGeAlD
Nilotinib—EPHB6—lung—asthma	0.000378	0.0036	CbGeAlD
Nilotinib—CA1—cardiovascular system—asthma	0.000378	0.0036	CbGeAlD
Nilotinib—MAP2K5—adrenal gland—asthma	0.000369	0.00352	CbGeAlD
Nilotinib—EPHB2—Diflorasone—Budesonide—asthma	0.000367	0.105	CbGdCrCtD
Nilotinib—EPHB2—Diflorasone—Flunisolide—asthma	0.000362	0.103	CbGdCrCtD
Nilotinib—CSF1R—adrenal gland—asthma	0.00036	0.00343	CbGeAlD
Nilotinib—ABL1—cardiovascular system—asthma	0.00036	0.00343	CbGeAlD
Nilotinib—PDGFRA—lung—asthma	0.000358	0.00342	CbGeAlD
Nilotinib—ABL1—trachea—asthma	0.000347	0.00331	CbGeAlD
Nilotinib—CA12—lung—asthma	0.000331	0.00315	CbGeAlD
Nilotinib—KIT—adrenal gland—asthma	0.000327	0.00312	CbGeAlD
Nilotinib—MAP2K5—lung—asthma	0.000323	0.00308	CbGeAlD
Nilotinib—CA2—respiratory system—asthma	0.00032	0.00305	CbGeAlD
Nilotinib—PDGFRB—adrenal gland—asthma	0.000319	0.00304	CbGeAlD
Nilotinib—CSF1R—lung—asthma	0.000315	0.00301	CbGeAlD
Nilotinib—Imatinib—ALB—asthma	0.000299	0.128	CrCbGaD
Nilotinib—EPHB2—Diflorasone—Mometasone—asthma	0.000297	0.0847	CbGdCrCtD
Nilotinib—CA4—cardiovascular system—asthma	0.000295	0.00282	CbGeAlD
Nilotinib—KIT—lung—asthma	0.000286	0.00273	CbGeAlD
Nilotinib—CA4—trachea—asthma	0.000285	0.00272	CbGeAlD
Nilotinib—ABL1—adrenal gland—asthma	0.000284	0.00271	CbGeAlD
Nilotinib—PDGFRB—lung—asthma	0.00028	0.00267	CbGeAlD
Nilotinib—CYP2B6—respiratory system—asthma	0.000273	0.00261	CbGeAlD
Nilotinib—CA2—adrenal cortex—asthma	0.000268	0.00256	CbGeAlD
Nilotinib—CA2—epithelium—asthma	0.000267	0.00255	CbGeAlD
Nilotinib—CA2—bronchus—asthma	0.000263	0.00251	CbGeAlD
Nilotinib—CA1—lung—asthma	0.000262	0.0025	CbGeAlD
Nilotinib—CA2—smooth muscle tissue—asthma	0.000257	0.00246	CbGeAlD
Nilotinib—ABL1—lung—asthma	0.000249	0.00238	CbGeAlD
Nilotinib—ABCG2—adrenal cortex—asthma	0.000248	0.00237	CbGeAlD
Nilotinib—CA2—cardiovascular system—asthma	0.000245	0.00234	CbGeAlD
Nilotinib—CA2—trachea—asthma	0.000236	0.00225	CbGeAlD
Nilotinib—CA4—adrenal gland—asthma	0.000234	0.00223	CbGeAlD
Nilotinib—CYP2B6—adrenal cortex—asthma	0.000229	0.00219	CbGeAlD
Nilotinib—CYP2B6—bronchus—asthma	0.000225	0.00214	CbGeAlD
Nilotinib—CYP2B6—cardiovascular system—asthma	0.000209	0.002	CbGeAlD
Nilotinib—CYP2C9—cardiovascular system—asthma	0.000207	0.00198	CbGeAlD
Nilotinib—CA4—lung—asthma	0.000205	0.00195	CbGeAlD
Nilotinib—CA2—adrenal gland—asthma	0.000194	0.00185	CbGeAlD
Nilotinib—ABCG2—adrenal gland—asthma	0.000179	0.00171	CbGeAlD
Nilotinib—EPHB2—Diflorasone—Methylprednisolone—asthma	0.000177	0.0506	CbGdCrCtD
Nilotinib—EPHB2—Diflorasone—Dexamethasone—asthma	0.000174	0.0498	CbGdCrCtD
Nilotinib—EPHB2—Diflorasone—Betamethasone—asthma	0.000174	0.0498	CbGdCrCtD
Nilotinib—EPHB2—Diflorasone—Triamcinolone—asthma	0.00017	0.0487	CbGdCrCtD
Nilotinib—CA2—lung—asthma	0.00017	0.00162	CbGeAlD
Nilotinib—CYP2B6—adrenal gland—asthma	0.000165	0.00158	CbGeAlD
Nilotinib—EPHB2—Diflorasone—Prednisone—asthma	0.000162	0.0462	CbGdCrCtD
Nilotinib—EPHB2—Diflorasone—Prednisolone—asthma	0.000158	0.0451	CbGdCrCtD
Nilotinib—ABCG2—lung—asthma	0.000157	0.0015	CbGeAlD
Nilotinib—ABCB1—respiratory system—asthma	0.000146	0.00139	CbGeAlD
Nilotinib—CYP2B6—lung—asthma	0.000145	0.00138	CbGeAlD
Nilotinib—ABCB1—adrenal cortex—asthma	0.000123	0.00117	CbGeAlD
Nilotinib—ABCB1—epithelium—asthma	0.000122	0.00116	CbGeAlD
Nilotinib—ABCB1—cardiovascular system—asthma	0.000112	0.00107	CbGeAlD
Nilotinib—ABCB1—trachea—asthma	0.000108	0.00103	CbGeAlD
Nilotinib—ABCB1—adrenal gland—asthma	8.84e-05	0.000844	CbGeAlD
Nilotinib—ABCB1—lung—asthma	7.75e-05	0.000739	CbGeAlD
Nilotinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	3.08e-05	0.000129	CcSEcCtD
Nilotinib—Syncope—Triamcinolone—asthma	3.07e-05	0.000129	CcSEcCtD
Nilotinib—Vertigo—Methylprednisolone—asthma	3.07e-05	0.000129	CcSEcCtD
Nilotinib—Syncope—Methylprednisolone—asthma	3.07e-05	0.000128	CcSEcCtD
Nilotinib—Discomfort—Hydrocortisone—asthma	3.06e-05	0.000128	CcSEcCtD
Nilotinib—Connective tissue disorder—Prednisone—asthma	3.06e-05	0.000128	CcSEcCtD
Nilotinib—Nausea—Budesonide—asthma	3.05e-05	0.000128	CcSEcCtD
Nilotinib—Oedema—Prednisolone—asthma	3.04e-05	0.000127	CcSEcCtD
Nilotinib—Loss of consciousness—Triamcinolone—asthma	3.01e-05	0.000126	CcSEcCtD
Nilotinib—Loss of consciousness—Methylprednisolone—asthma	3e-05	0.000126	CcSEcCtD
Nilotinib—Shock—Prednisolone—asthma	2.99e-05	0.000125	CcSEcCtD
Nilotinib—Cough—Triamcinolone—asthma	2.99e-05	0.000125	CcSEcCtD
Nilotinib—Oedema—Hydrocortisone—asthma	2.97e-05	0.000124	CcSEcCtD
Nilotinib—Tachycardia—Prednisolone—asthma	2.97e-05	0.000124	CcSEcCtD
Nilotinib—Hypertension—Triamcinolone—asthma	2.96e-05	0.000124	CcSEcCtD
Nilotinib—Hypertension—Methylprednisolone—asthma	2.95e-05	0.000124	CcSEcCtD
Nilotinib—Infection—Hydrocortisone—asthma	2.95e-05	0.000124	CcSEcCtD
Nilotinib—Hyperhidrosis—Prednisolone—asthma	2.94e-05	0.000123	CcSEcCtD
Nilotinib—Shock—Hydrocortisone—asthma	2.92e-05	0.000122	CcSEcCtD
Nilotinib—Myalgia—Triamcinolone—asthma	2.92e-05	0.000122	CcSEcCtD
Nilotinib—Nervous system disorder—Hydrocortisone—asthma	2.91e-05	0.000122	CcSEcCtD
Nilotinib—Myalgia—Methylprednisolone—asthma	2.91e-05	0.000122	CcSEcCtD
Nilotinib—Arthralgia—Methylprednisolone—asthma	2.91e-05	0.000122	CcSEcCtD
Nilotinib—Eye disorder—Prednisone—asthma	2.91e-05	0.000122	CcSEcCtD
Nilotinib—Anxiety—Methylprednisolone—asthma	2.9e-05	0.000122	CcSEcCtD
Nilotinib—Tachycardia—Hydrocortisone—asthma	2.9e-05	0.000121	CcSEcCtD
Nilotinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	2.89e-05	0.000121	CcSEcCtD
Nilotinib—Flushing—Prednisone—asthma	2.89e-05	0.000121	CcSEcCtD
Nilotinib—Skin disorder—Hydrocortisone—asthma	2.88e-05	0.000121	CcSEcCtD
Nilotinib—Ill-defined disorder—Dexamethasone—asthma	2.88e-05	0.000121	CcSEcCtD
Nilotinib—Ill-defined disorder—Betamethasone—asthma	2.88e-05	0.000121	CcSEcCtD
Nilotinib—Discomfort—Triamcinolone—asthma	2.88e-05	0.000121	CcSEcCtD
Nilotinib—Discomfort—Methylprednisolone—asthma	2.88e-05	0.000121	CcSEcCtD
Nilotinib—Hyperhidrosis—Hydrocortisone—asthma	2.87e-05	0.00012	CcSEcCtD
Nilotinib—Dry mouth—Triamcinolone—asthma	2.85e-05	0.00012	CcSEcCtD
Nilotinib—Anorexia—Hydrocortisone—asthma	2.83e-05	0.000119	CcSEcCtD
Nilotinib—Angiopathy—Prednisone—asthma	2.82e-05	0.000118	CcSEcCtD
Nilotinib—Confusional state—Methylprednisolone—asthma	2.81e-05	0.000118	CcSEcCtD
Nilotinib—Immune system disorder—Prednisone—asthma	2.81e-05	0.000118	CcSEcCtD
Nilotinib—Malaise—Betamethasone—asthma	2.8e-05	0.000118	CcSEcCtD
Nilotinib—Malaise—Dexamethasone—asthma	2.8e-05	0.000118	CcSEcCtD
Nilotinib—Oedema—Triamcinolone—asthma	2.8e-05	0.000117	CcSEcCtD
Nilotinib—Vertigo—Dexamethasone—asthma	2.79e-05	0.000117	CcSEcCtD
Nilotinib—Vertigo—Betamethasone—asthma	2.79e-05	0.000117	CcSEcCtD
Nilotinib—Syncope—Betamethasone—asthma	2.79e-05	0.000117	CcSEcCtD
Nilotinib—Syncope—Dexamethasone—asthma	2.79e-05	0.000117	CcSEcCtD
Nilotinib—Arrhythmia—Prednisone—asthma	2.78e-05	0.000116	CcSEcCtD
Nilotinib—Infection—Triamcinolone—asthma	2.78e-05	0.000116	CcSEcCtD
Nilotinib—Hypotension—Hydrocortisone—asthma	2.77e-05	0.000116	CcSEcCtD
Nilotinib—Infection—Methylprednisolone—asthma	2.77e-05	0.000116	CcSEcCtD
Nilotinib—Shock—Triamcinolone—asthma	2.75e-05	0.000115	CcSEcCtD
Nilotinib—Insomnia—Prednisolone—asthma	2.75e-05	0.000115	CcSEcCtD
Nilotinib—Alopecia—Prednisone—asthma	2.75e-05	0.000115	CcSEcCtD
Nilotinib—Shock—Methylprednisolone—asthma	2.74e-05	0.000115	CcSEcCtD
Nilotinib—Nervous system disorder—Methylprednisolone—asthma	2.74e-05	0.000115	CcSEcCtD
Nilotinib—Loss of consciousness—Betamethasone—asthma	2.73e-05	0.000115	CcSEcCtD
Nilotinib—Loss of consciousness—Dexamethasone—asthma	2.73e-05	0.000115	CcSEcCtD
Nilotinib—Paraesthesia—Prednisolone—asthma	2.73e-05	0.000114	CcSEcCtD
Nilotinib—Tachycardia—Triamcinolone—asthma	2.73e-05	0.000114	CcSEcCtD
Nilotinib—Mental disorder—Prednisone—asthma	2.72e-05	0.000114	CcSEcCtD
Nilotinib—Tachycardia—Methylprednisolone—asthma	2.72e-05	0.000114	CcSEcCtD
Nilotinib—Skin disorder—Methylprednisolone—asthma	2.71e-05	0.000114	CcSEcCtD
Nilotinib—Erythema—Prednisone—asthma	2.71e-05	0.000113	CcSEcCtD
Nilotinib—Malnutrition—Prednisone—asthma	2.71e-05	0.000113	CcSEcCtD
Nilotinib—Musculoskeletal discomfort—Hydrocortisone—asthma	2.71e-05	0.000113	CcSEcCtD
Nilotinib—Hyperhidrosis—Triamcinolone—asthma	2.7e-05	0.000113	CcSEcCtD
Nilotinib—Hyperhidrosis—Methylprednisolone—asthma	2.7e-05	0.000113	CcSEcCtD
Nilotinib—Insomnia—Hydrocortisone—asthma	2.69e-05	0.000113	CcSEcCtD
Nilotinib—Hypertension—Betamethasone—asthma	2.68e-05	0.000113	CcSEcCtD
Nilotinib—Hypertension—Dexamethasone—asthma	2.68e-05	0.000113	CcSEcCtD
Nilotinib—Paraesthesia—Hydrocortisone—asthma	2.67e-05	0.000112	CcSEcCtD
Nilotinib—Myalgia—Dexamethasone—asthma	2.65e-05	0.000111	CcSEcCtD
Nilotinib—Myalgia—Betamethasone—asthma	2.65e-05	0.000111	CcSEcCtD
Nilotinib—Anxiety—Betamethasone—asthma	2.64e-05	0.000111	CcSEcCtD
Nilotinib—Anxiety—Dexamethasone—asthma	2.64e-05	0.000111	CcSEcCtD
Nilotinib—Discomfort—Dexamethasone—asthma	2.61e-05	0.00011	CcSEcCtD
Nilotinib—Discomfort—Betamethasone—asthma	2.61e-05	0.00011	CcSEcCtD
Nilotinib—Dyspepsia—Hydrocortisone—asthma	2.61e-05	0.00011	CcSEcCtD
Nilotinib—Hypotension—Methylprednisolone—asthma	2.61e-05	0.000109	CcSEcCtD
Nilotinib—Pain—Prednisolone—asthma	2.6e-05	0.000109	CcSEcCtD
Nilotinib—Decreased appetite—Hydrocortisone—asthma	2.58e-05	0.000108	CcSEcCtD
Nilotinib—Gastrointestinal disorder—Hydrocortisone—asthma	2.56e-05	0.000107	CcSEcCtD
Nilotinib—Fatigue—Hydrocortisone—asthma	2.56e-05	0.000107	CcSEcCtD
Nilotinib—Vision blurred—Prednisone—asthma	2.55e-05	0.000107	CcSEcCtD
Nilotinib—Musculoskeletal discomfort—Triamcinolone—asthma	2.55e-05	0.000107	CcSEcCtD
Nilotinib—Musculoskeletal discomfort—Methylprednisolone—asthma	2.54e-05	0.000107	CcSEcCtD
Nilotinib—Pain—Hydrocortisone—asthma	2.54e-05	0.000106	CcSEcCtD
Nilotinib—Oedema—Betamethasone—asthma	2.54e-05	0.000106	CcSEcCtD
Nilotinib—Oedema—Dexamethasone—asthma	2.54e-05	0.000106	CcSEcCtD
Nilotinib—Insomnia—Triamcinolone—asthma	2.53e-05	0.000106	CcSEcCtD
Nilotinib—Insomnia—Methylprednisolone—asthma	2.52e-05	0.000106	CcSEcCtD
Nilotinib—Infection—Betamethasone—asthma	2.52e-05	0.000106	CcSEcCtD
Nilotinib—Infection—Dexamethasone—asthma	2.52e-05	0.000106	CcSEcCtD
Nilotinib—Ill-defined disorder—Prednisone—asthma	2.51e-05	0.000105	CcSEcCtD
Nilotinib—Paraesthesia—Triamcinolone—asthma	2.51e-05	0.000105	CcSEcCtD
Nilotinib—Feeling abnormal—Prednisolone—asthma	2.51e-05	0.000105	CcSEcCtD
Nilotinib—Paraesthesia—Methylprednisolone—asthma	2.5e-05	0.000105	CcSEcCtD
Nilotinib—Anaemia—Prednisone—asthma	2.5e-05	0.000105	CcSEcCtD
Nilotinib—Shock—Dexamethasone—asthma	2.5e-05	0.000105	CcSEcCtD
Nilotinib—Shock—Betamethasone—asthma	2.5e-05	0.000105	CcSEcCtD
Nilotinib—Dyspnoea—Triamcinolone—asthma	2.49e-05	0.000104	CcSEcCtD
Nilotinib—Nervous system disorder—Dexamethasone—asthma	2.49e-05	0.000104	CcSEcCtD
Nilotinib—Nervous system disorder—Betamethasone—asthma	2.49e-05	0.000104	CcSEcCtD
Nilotinib—Thrombocytopenia—Dexamethasone—asthma	2.48e-05	0.000104	CcSEcCtD
Nilotinib—Thrombocytopenia—Betamethasone—asthma	2.48e-05	0.000104	CcSEcCtD
Nilotinib—Tachycardia—Betamethasone—asthma	2.48e-05	0.000104	CcSEcCtD
Nilotinib—Tachycardia—Dexamethasone—asthma	2.48e-05	0.000104	CcSEcCtD
Nilotinib—Dyspepsia—Triamcinolone—asthma	2.46e-05	0.000103	CcSEcCtD
Nilotinib—Dyspepsia—Methylprednisolone—asthma	2.46e-05	0.000103	CcSEcCtD
Nilotinib—Hyperhidrosis—Betamethasone—asthma	2.45e-05	0.000103	CcSEcCtD
Nilotinib—Hyperhidrosis—Dexamethasone—asthma	2.45e-05	0.000103	CcSEcCtD
Nilotinib—Feeling abnormal—Hydrocortisone—asthma	2.45e-05	0.000103	CcSEcCtD
Nilotinib—Malaise—Prednisone—asthma	2.44e-05	0.000102	CcSEcCtD
Nilotinib—Vertigo—Prednisone—asthma	2.43e-05	0.000102	CcSEcCtD
Nilotinib—Gastrointestinal pain—Hydrocortisone—asthma	2.43e-05	0.000102	CcSEcCtD
Nilotinib—Syncope—Prednisone—asthma	2.43e-05	0.000102	CcSEcCtD
Nilotinib—Anorexia—Dexamethasone—asthma	2.42e-05	0.000101	CcSEcCtD
Nilotinib—Anorexia—Betamethasone—asthma	2.42e-05	0.000101	CcSEcCtD
Nilotinib—Urticaria—Prednisolone—asthma	2.42e-05	0.000101	CcSEcCtD
Nilotinib—Fatigue—Triamcinolone—asthma	2.41e-05	0.000101	CcSEcCtD
Nilotinib—Fatigue—Methylprednisolone—asthma	2.41e-05	0.000101	CcSEcCtD
Nilotinib—Pain—Triamcinolone—asthma	2.39e-05	0.0001	CcSEcCtD
Nilotinib—Loss of consciousness—Prednisone—asthma	2.38e-05	9.97e-05	CcSEcCtD
Nilotinib—Hypotension—Betamethasone—asthma	2.37e-05	9.94e-05	CcSEcCtD
Nilotinib—Hypotension—Dexamethasone—asthma	2.37e-05	9.94e-05	CcSEcCtD
Nilotinib—Urticaria—Hydrocortisone—asthma	2.36e-05	9.89e-05	CcSEcCtD
Nilotinib—Body temperature increased—Hydrocortisone—asthma	2.35e-05	9.84e-05	CcSEcCtD
Nilotinib—Abdominal pain—Hydrocortisone—asthma	2.35e-05	9.84e-05	CcSEcCtD
Nilotinib—Hypertension—Prednisone—asthma	2.34e-05	9.8e-05	CcSEcCtD
Nilotinib—Musculoskeletal discomfort—Dexamethasone—asthma	2.31e-05	9.69e-05	CcSEcCtD
Nilotinib—Musculoskeletal discomfort—Betamethasone—asthma	2.31e-05	9.69e-05	CcSEcCtD
Nilotinib—Arthralgia—Prednisone—asthma	2.3e-05	9.66e-05	CcSEcCtD
Nilotinib—Myalgia—Prednisone—asthma	2.3e-05	9.66e-05	CcSEcCtD
Nilotinib—Feeling abnormal—Triamcinolone—asthma	2.3e-05	9.66e-05	CcSEcCtD
Nilotinib—Feeling abnormal—Methylprednisolone—asthma	2.3e-05	9.64e-05	CcSEcCtD
Nilotinib—Anxiety—Prednisone—asthma	2.3e-05	9.63e-05	CcSEcCtD
Nilotinib—Insomnia—Betamethasone—asthma	2.29e-05	9.62e-05	CcSEcCtD
Nilotinib—Insomnia—Dexamethasone—asthma	2.29e-05	9.62e-05	CcSEcCtD
Nilotinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	2.29e-05	9.59e-05	CcSEcCtD
Nilotinib—Gastrointestinal pain—Methylprednisolone—asthma	2.28e-05	9.56e-05	CcSEcCtD
Nilotinib—Paraesthesia—Betamethasone—asthma	2.28e-05	9.55e-05	CcSEcCtD
Nilotinib—Paraesthesia—Dexamethasone—asthma	2.28e-05	9.55e-05	CcSEcCtD
Nilotinib—Discomfort—Prednisone—asthma	2.28e-05	9.55e-05	CcSEcCtD
Nilotinib—Hypersensitivity—Prednisolone—asthma	2.24e-05	9.39e-05	CcSEcCtD
Nilotinib—Dyspepsia—Betamethasone—asthma	2.23e-05	9.36e-05	CcSEcCtD
Nilotinib—Dyspepsia—Dexamethasone—asthma	2.23e-05	9.36e-05	CcSEcCtD
Nilotinib—Urticaria—Triamcinolone—asthma	2.22e-05	9.31e-05	CcSEcCtD
Nilotinib—Urticaria—Methylprednisolone—asthma	2.22e-05	9.29e-05	CcSEcCtD
Nilotinib—Body temperature increased—Triamcinolone—asthma	2.21e-05	9.27e-05	CcSEcCtD
Nilotinib—Oedema—Prednisone—asthma	2.21e-05	9.26e-05	CcSEcCtD
Nilotinib—Abdominal pain—Methylprednisolone—asthma	2.21e-05	9.24e-05	CcSEcCtD
Nilotinib—Decreased appetite—Dexamethasone—asthma	2.21e-05	9.24e-05	CcSEcCtD
Nilotinib—Decreased appetite—Betamethasone—asthma	2.21e-05	9.24e-05	CcSEcCtD
Nilotinib—Infection—Prednisone—asthma	2.19e-05	9.2e-05	CcSEcCtD
Nilotinib—Gastrointestinal disorder—Betamethasone—asthma	2.19e-05	9.18e-05	CcSEcCtD
Nilotinib—Gastrointestinal disorder—Dexamethasone—asthma	2.19e-05	9.18e-05	CcSEcCtD
Nilotinib—Hypersensitivity—Hydrocortisone—asthma	2.19e-05	9.17e-05	CcSEcCtD
Nilotinib—Fatigue—Dexamethasone—asthma	2.19e-05	9.17e-05	CcSEcCtD
Nilotinib—Fatigue—Betamethasone—asthma	2.19e-05	9.17e-05	CcSEcCtD
Nilotinib—Shock—Prednisone—asthma	2.17e-05	9.11e-05	CcSEcCtD
Nilotinib—Pain—Betamethasone—asthma	2.17e-05	9.09e-05	CcSEcCtD
Nilotinib—Pain—Dexamethasone—asthma	2.17e-05	9.09e-05	CcSEcCtD
Nilotinib—Nervous system disorder—Prednisone—asthma	2.17e-05	9.08e-05	CcSEcCtD
Nilotinib—Tachycardia—Prednisone—asthma	2.16e-05	9.04e-05	CcSEcCtD
Nilotinib—Skin disorder—Prednisone—asthma	2.15e-05	9e-05	CcSEcCtD
Nilotinib—Hyperhidrosis—Prednisone—asthma	2.14e-05	8.95e-05	CcSEcCtD
Nilotinib—Asthenia—Hydrocortisone—asthma	2.13e-05	8.93e-05	CcSEcCtD
Nilotinib—Anorexia—Prednisone—asthma	2.11e-05	8.83e-05	CcSEcCtD
Nilotinib—Pruritus—Hydrocortisone—asthma	2.1e-05	8.81e-05	CcSEcCtD
Nilotinib—Feeling abnormal—Dexamethasone—asthma	2.09e-05	8.76e-05	CcSEcCtD
Nilotinib—Feeling abnormal—Betamethasone—asthma	2.09e-05	8.76e-05	CcSEcCtD
Nilotinib—Gastrointestinal pain—Dexamethasone—asthma	2.07e-05	8.7e-05	CcSEcCtD
Nilotinib—Gastrointestinal pain—Betamethasone—asthma	2.07e-05	8.7e-05	CcSEcCtD
Nilotinib—Hypersensitivity—Triamcinolone—asthma	2.06e-05	8.64e-05	CcSEcCtD
Nilotinib—Hypersensitivity—Methylprednisolone—asthma	2.06e-05	8.62e-05	CcSEcCtD
Nilotinib—Diarrhoea—Hydrocortisone—asthma	2.03e-05	8.52e-05	CcSEcCtD
Nilotinib—Urticaria—Betamethasone—asthma	2.02e-05	8.45e-05	CcSEcCtD
Nilotinib—Urticaria—Dexamethasone—asthma	2.02e-05	8.45e-05	CcSEcCtD
Nilotinib—Musculoskeletal discomfort—Prednisone—asthma	2.01e-05	8.44e-05	CcSEcCtD
Nilotinib—Dizziness—Prednisolone—asthma	2.01e-05	8.43e-05	CcSEcCtD
Nilotinib—Asthenia—Triamcinolone—asthma	2.01e-05	8.41e-05	CcSEcCtD
Nilotinib—Abdominal pain—Dexamethasone—asthma	2.01e-05	8.41e-05	CcSEcCtD
Nilotinib—Body temperature increased—Dexamethasone—asthma	2.01e-05	8.41e-05	CcSEcCtD
Nilotinib—Abdominal pain—Betamethasone—asthma	2.01e-05	8.41e-05	CcSEcCtD
Nilotinib—Body temperature increased—Betamethasone—asthma	2.01e-05	8.41e-05	CcSEcCtD
Nilotinib—Asthenia—Methylprednisolone—asthma	2e-05	8.39e-05	CcSEcCtD
Nilotinib—Insomnia—Prednisone—asthma	2e-05	8.38e-05	CcSEcCtD
Nilotinib—Paraesthesia—Prednisone—asthma	1.98e-05	8.32e-05	CcSEcCtD
Nilotinib—Pruritus—Triamcinolone—asthma	1.98e-05	8.29e-05	CcSEcCtD
Nilotinib—Pruritus—Methylprednisolone—asthma	1.97e-05	8.27e-05	CcSEcCtD
Nilotinib—Dizziness—Hydrocortisone—asthma	1.96e-05	8.23e-05	CcSEcCtD
Nilotinib—Dyspepsia—Prednisone—asthma	1.94e-05	8.15e-05	CcSEcCtD
Nilotinib—Decreased appetite—Prednisone—asthma	1.92e-05	8.05e-05	CcSEcCtD
Nilotinib—Rash—Prednisolone—asthma	1.92e-05	8.04e-05	CcSEcCtD
Nilotinib—Dermatitis—Prednisolone—asthma	1.92e-05	8.03e-05	CcSEcCtD
Nilotinib—Diarrhoea—Methylprednisolone—asthma	1.91e-05	8e-05	CcSEcCtD
Nilotinib—Fatigue—Prednisone—asthma	1.9e-05	7.98e-05	CcSEcCtD
Nilotinib—Headache—Prednisolone—asthma	1.9e-05	7.98e-05	CcSEcCtD
Nilotinib—Constipation—Prednisone—asthma	1.89e-05	7.92e-05	CcSEcCtD
Nilotinib—Vomiting—Hydrocortisone—asthma	1.89e-05	7.91e-05	CcSEcCtD
Nilotinib—Rash—Hydrocortisone—asthma	1.87e-05	7.85e-05	CcSEcCtD
Nilotinib—Dermatitis—Hydrocortisone—asthma	1.87e-05	7.84e-05	CcSEcCtD
Nilotinib—Headache—Hydrocortisone—asthma	1.86e-05	7.8e-05	CcSEcCtD
Nilotinib—Dizziness—Triamcinolone—asthma	1.85e-05	7.75e-05	CcSEcCtD
Nilotinib—Dizziness—Methylprednisolone—asthma	1.84e-05	7.73e-05	CcSEcCtD
Nilotinib—Feeling abnormal—Prednisone—asthma	1.82e-05	7.63e-05	CcSEcCtD
Nilotinib—Asthenia—Betamethasone—asthma	1.82e-05	7.63e-05	CcSEcCtD
Nilotinib—Asthenia—Dexamethasone—asthma	1.82e-05	7.63e-05	CcSEcCtD
Nilotinib—Gastrointestinal pain—Prednisone—asthma	1.81e-05	7.57e-05	CcSEcCtD
Nilotinib—Nausea—Prednisolone—asthma	1.81e-05	7.57e-05	CcSEcCtD
Nilotinib—Pruritus—Betamethasone—asthma	1.79e-05	7.52e-05	CcSEcCtD
Nilotinib—Pruritus—Dexamethasone—asthma	1.79e-05	7.52e-05	CcSEcCtD
Nilotinib—Vomiting—Triamcinolone—asthma	1.78e-05	7.45e-05	CcSEcCtD
Nilotinib—Vomiting—Methylprednisolone—asthma	1.77e-05	7.44e-05	CcSEcCtD
Nilotinib—Nausea—Hydrocortisone—asthma	1.76e-05	7.39e-05	CcSEcCtD
Nilotinib—Rash—Triamcinolone—asthma	1.76e-05	7.39e-05	CcSEcCtD
Nilotinib—Dermatitis—Triamcinolone—asthma	1.76e-05	7.38e-05	CcSEcCtD
Nilotinib—Rash—Methylprednisolone—asthma	1.76e-05	7.37e-05	CcSEcCtD
Nilotinib—Dermatitis—Methylprednisolone—asthma	1.76e-05	7.37e-05	CcSEcCtD
Nilotinib—Urticaria—Prednisone—asthma	1.76e-05	7.36e-05	CcSEcCtD
Nilotinib—Headache—Triamcinolone—asthma	1.75e-05	7.34e-05	CcSEcCtD
Nilotinib—Headache—Methylprednisolone—asthma	1.75e-05	7.33e-05	CcSEcCtD
Nilotinib—Abdominal pain—Prednisone—asthma	1.75e-05	7.32e-05	CcSEcCtD
Nilotinib—Body temperature increased—Prednisone—asthma	1.75e-05	7.32e-05	CcSEcCtD
Nilotinib—Diarrhoea—Betamethasone—asthma	1.74e-05	7.28e-05	CcSEcCtD
Nilotinib—Diarrhoea—Dexamethasone—asthma	1.74e-05	7.28e-05	CcSEcCtD
Nilotinib—Dizziness—Dexamethasone—asthma	1.68e-05	7.03e-05	CcSEcCtD
Nilotinib—Dizziness—Betamethasone—asthma	1.68e-05	7.03e-05	CcSEcCtD
Nilotinib—Nausea—Triamcinolone—asthma	1.66e-05	6.96e-05	CcSEcCtD
Nilotinib—Nausea—Methylprednisolone—asthma	1.66e-05	6.95e-05	CcSEcCtD
Nilotinib—Hypersensitivity—Prednisone—asthma	1.63e-05	6.82e-05	CcSEcCtD
Nilotinib—Vomiting—Dexamethasone—asthma	1.61e-05	6.76e-05	CcSEcCtD
Nilotinib—Vomiting—Betamethasone—asthma	1.61e-05	6.76e-05	CcSEcCtD
Nilotinib—Rash—Betamethasone—asthma	1.6e-05	6.71e-05	CcSEcCtD
Nilotinib—Rash—Dexamethasone—asthma	1.6e-05	6.71e-05	CcSEcCtD
Nilotinib—Dermatitis—Dexamethasone—asthma	1.6e-05	6.7e-05	CcSEcCtD
Nilotinib—Dermatitis—Betamethasone—asthma	1.6e-05	6.7e-05	CcSEcCtD
Nilotinib—Headache—Dexamethasone—asthma	1.59e-05	6.66e-05	CcSEcCtD
Nilotinib—Headache—Betamethasone—asthma	1.59e-05	6.66e-05	CcSEcCtD
Nilotinib—Asthenia—Prednisone—asthma	1.59e-05	6.64e-05	CcSEcCtD
Nilotinib—Pruritus—Prednisone—asthma	1.56e-05	6.55e-05	CcSEcCtD
Nilotinib—Diarrhoea—Prednisone—asthma	1.51e-05	6.34e-05	CcSEcCtD
Nilotinib—Nausea—Dexamethasone—asthma	1.51e-05	6.32e-05	CcSEcCtD
Nilotinib—Nausea—Betamethasone—asthma	1.51e-05	6.32e-05	CcSEcCtD
Nilotinib—Dizziness—Prednisone—asthma	1.46e-05	6.12e-05	CcSEcCtD
Nilotinib—Vomiting—Prednisone—asthma	1.4e-05	5.89e-05	CcSEcCtD
Nilotinib—Rash—Prednisone—asthma	1.39e-05	5.84e-05	CcSEcCtD
Nilotinib—Dermatitis—Prednisone—asthma	1.39e-05	5.83e-05	CcSEcCtD
Nilotinib—Headache—Prednisone—asthma	1.38e-05	5.8e-05	CcSEcCtD
Nilotinib—Nausea—Prednisone—asthma	1.31e-05	5.5e-05	CcSEcCtD
Nilotinib—UGT1A1—Metabolism—ALB—asthma	2.08e-06	1.15e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—PTEN—asthma	2.08e-06	1.15e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—CD4—asthma	2.07e-06	1.15e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—CXCL8—asthma	2.07e-06	1.15e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—PTEN—asthma	2.07e-06	1.14e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—STAT3—asthma	2.05e-06	1.13e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—POMC—asthma	2.04e-06	1.13e-05	CbGpPWpGaD
Nilotinib—ABCB1—Transmembrane transport of small molecules—ALB—asthma	2.03e-06	1.12e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—CCL2—asthma	2.03e-06	1.12e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—RHOA—asthma	2.03e-06	1.12e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—PDGFB—asthma	2.03e-06	1.12e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—IL6R—asthma	2.03e-06	1.12e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—VEGFA—asthma	2.03e-06	1.12e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—EGFR—asthma	2.02e-06	1.12e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—NOS3—asthma	2.01e-06	1.11e-05	CbGpPWpGaD
Nilotinib—KIT—Disease—TGFB1—asthma	2.01e-06	1.11e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—STAT3—asthma	2.01e-06	1.11e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—PLA2G4A—asthma	2e-06	1.11e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—GSTM1—asthma	2e-06	1.11e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—STAT3—asthma	2e-06	1.11e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—IL2—asthma	2e-06	1.1e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—asthma	2e-06	1.1e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—CCL2—asthma	1.99e-06	1.1e-05	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—NOS3—asthma	1.99e-06	1.1e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—IL6R—asthma	1.99e-06	1.1e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—IL2—asthma	1.98e-06	1.09e-05	CbGpPWpGaD
Nilotinib—KIT—Disease—EGFR—asthma	1.97e-06	1.09e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—STAT3—asthma	1.96e-06	1.08e-05	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—TGFB1—asthma	1.96e-06	1.08e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—STAT3—asthma	1.95e-06	1.08e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—LEP—asthma	1.94e-06	1.07e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ALOX15—asthma	1.93e-06	1.07e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ALOX5AP—asthma	1.93e-06	1.07e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—POMC—asthma	1.93e-06	1.07e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—POMC—asthma	1.93e-06	1.07e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—NQO1—asthma	1.93e-06	1.07e-05	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—IL6—asthma	1.93e-06	1.06e-05	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—EGFR—asthma	1.92e-06	1.06e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—IL1B—asthma	1.91e-06	1.06e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—CD4—asthma	1.91e-06	1.06e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—IL2—asthma	1.91e-06	1.05e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—TGFB1—asthma	1.9e-06	1.05e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—PTGS2—asthma	1.9e-06	1.05e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—SERPINE1—asthma	1.9e-06	1.05e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—MMP9—asthma	1.89e-06	1.05e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—CCL2—asthma	1.89e-06	1.04e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—ADCY2—asthma	1.89e-06	1.04e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—CXCL8—asthma	1.89e-06	1.04e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—IL6R—asthma	1.88e-06	1.04e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—PTEN—asthma	1.88e-06	1.04e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—MMP9—asthma	1.87e-06	1.04e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—asthma	1.87e-06	1.04e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—EGFR—asthma	1.86e-06	1.03e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—PTEN—asthma	1.86e-06	1.03e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—TGFB1—asthma	1.86e-06	1.03e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—SERPINE1—asthma	1.86e-06	1.03e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—STAT3—asthma	1.86e-06	1.03e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—STAT3—asthma	1.85e-06	1.02e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—GSTP1—asthma	1.85e-06	1.02e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—PPP2CA—asthma	1.85e-06	1.02e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CHAT—asthma	1.84e-06	1.02e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—RHOA—asthma	1.83e-06	1.01e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—FN1—asthma	1.83e-06	1.01e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—EGFR—asthma	1.82e-06	1.01e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—HMOX1—asthma	1.82e-06	1.01e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—EGFR—asthma	1.82e-06	1e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—NQO1—asthma	1.82e-06	1e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—ITPR1—asthma	1.82e-06	1e-05	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—IL6—asthma	1.82e-06	1e-05	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—PTGS2—asthma	1.82e-06	1e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—NOS3—asthma	1.81e-06	1e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—IL2—asthma	1.8e-06	9.96e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—NQO1—asthma	1.8e-06	9.96e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—CAT—asthma	1.8e-06	9.93e-06	CbGpPWpGaD
Nilotinib—LCK—Immune System—PTEN—asthma	1.8e-06	9.92e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—RHOA—asthma	1.79e-06	9.91e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—CXCL8—asthma	1.79e-06	9.87e-06	CbGpPWpGaD
Nilotinib—LYN—Immune System—EGFR—asthma	1.78e-06	9.84e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—ADCY2—asthma	1.78e-06	9.83e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—NOS3—asthma	1.78e-06	9.81e-06	CbGpPWpGaD
Nilotinib—ABL1—Immune System—EGFR—asthma	1.77e-06	9.79e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—ADCY2—asthma	1.76e-06	9.75e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—SERPINE1—asthma	1.76e-06	9.74e-06	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—ALB—asthma	1.76e-06	9.74e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—asthma	1.75e-06	9.66e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—TGFB1—asthma	1.71e-06	9.46e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—IL2—asthma	1.71e-06	9.43e-06	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—MMP9—asthma	1.71e-06	9.43e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—RHOA—asthma	1.7e-06	9.4e-06	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—VEGFA—asthma	1.7e-06	9.39e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—PLA2G4A—asthma	1.7e-06	9.38e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—GSTM1—asthma	1.7e-06	9.38e-06	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—PTEN—asthma	1.7e-06	9.37e-06	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—EGFR—asthma	1.69e-06	9.33e-06	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—NOS3—asthma	1.69e-06	9.32e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—NOS3—asthma	1.68e-06	9.3e-06	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—VEGFA—asthma	1.68e-06	9.3e-06	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—STAT3—asthma	1.68e-06	9.3e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—EGFR—asthma	1.68e-06	9.28e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—POMC—asthma	1.67e-06	9.22e-06	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—STAT3—asthma	1.67e-06	9.21e-06	CbGpPWpGaD
Nilotinib—BRAF—Disease—IL6—asthma	1.66e-06	9.19e-06	CbGpPWpGaD
Nilotinib—LCK—Disease—PTEN—asthma	1.66e-06	9.16e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ALOX5—asthma	1.64e-06	9.09e-06	CbGpPWpGaD
Nilotinib—KIT—Immune System—IL6—asthma	1.64e-06	9.06e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CCL2—asthma	1.63e-06	9.02e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—IL6R—asthma	1.63e-06	9e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—MMP9—asthma	1.61e-06	8.92e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—GSTP1—asthma	1.61e-06	8.89e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—CXCL8—asthma	1.61e-06	8.89e-06	CbGpPWpGaD
Nilotinib—LCK—Immune System—STAT3—asthma	1.61e-06	8.87e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—PTEN—asthma	1.61e-06	8.87e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—HMOX1—asthma	1.59e-06	8.77e-06	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—PTEN—asthma	1.58e-06	8.76e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—ITPR1—asthma	1.58e-06	8.75e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—CXCL8—asthma	1.57e-06	8.7e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CARM1—asthma	1.57e-06	8.67e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CAT—asthma	1.57e-06	8.65e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—PPP2CA—asthma	1.56e-06	8.64e-06	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—TGFB1—asthma	1.56e-06	8.62e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—IL6—asthma	1.55e-06	8.57e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—DCN—asthma	1.55e-06	8.54e-06	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—TGFB1—asthma	1.54e-06	8.54e-06	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—PTGS2—asthma	1.54e-06	8.52e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—IL2—asthma	1.54e-06	8.5e-06	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—VEGFA—asthma	1.53e-06	8.47e-06	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—EGFR—asthma	1.53e-06	8.45e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—asthma	1.52e-06	8.43e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—SERPINE1—asthma	1.52e-06	8.42e-06	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—STAT3—asthma	1.52e-06	8.38e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—GSTP1—asthma	1.52e-06	8.38e-06	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—EGFR—asthma	1.51e-06	8.37e-06	CbGpPWpGaD
Nilotinib—KIT—Disease—IL6—asthma	1.51e-06	8.36e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—IL2—asthma	1.5e-06	8.32e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ALDH2—asthma	1.5e-06	8.31e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—GSTP1—asthma	1.5e-06	8.31e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—HMOX1—asthma	1.5e-06	8.27e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—CXCL8—asthma	1.49e-06	8.25e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—ITPR1—asthma	1.49e-06	8.25e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—HMOX1—asthma	1.48e-06	8.19e-06	CbGpPWpGaD
Nilotinib—LCK—Disease—STAT3—asthma	1.48e-06	8.19e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—ITPR1—asthma	1.48e-06	8.18e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PLA2G4A—asthma	1.48e-06	8.17e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—GSTM1—asthma	1.48e-06	8.17e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CAT—asthma	1.48e-06	8.16e-06	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—IL6—asthma	1.47e-06	8.15e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—RHOA—asthma	1.47e-06	8.13e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CAT—asthma	1.46e-06	8.08e-06	CbGpPWpGaD
Nilotinib—LCK—Immune System—EGFR—asthma	1.46e-06	8.06e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—NOS3—asthma	1.46e-06	8.04e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—MMP9—asthma	1.45e-06	8.04e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—VEGFA—asthma	1.45e-06	8.01e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—PTEN—asthma	1.45e-06	7.99e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—STAT3—asthma	1.44e-06	7.94e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—IL6—asthma	1.43e-06	7.92e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GSTT1—asthma	1.43e-06	7.91e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—IL2—asthma	1.43e-06	7.89e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—MMP9—asthma	1.42e-06	7.87e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—POMC—asthma	1.42e-06	7.83e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—PTEN—asthma	1.42e-06	7.83e-06	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—TGFB1—asthma	1.41e-06	7.77e-06	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—IL6—asthma	1.4e-06	7.75e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—IL6—asthma	1.4e-06	7.72e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—GSTM1—asthma	1.39e-06	7.7e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PLA2G4A—asthma	1.39e-06	7.7e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PLA2G4A—asthma	1.38e-06	7.63e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—GSTM1—asthma	1.38e-06	7.63e-06	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—EGFR—asthma	1.38e-06	7.62e-06	CbGpPWpGaD
Nilotinib—LCK—Disease—TGFB1—asthma	1.37e-06	7.59e-06	CbGpPWpGaD
Nilotinib—LYN—Immune System—IL6—asthma	1.37e-06	7.56e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PPP2CA—asthma	1.36e-06	7.53e-06	CbGpPWpGaD
Nilotinib—ABL1—Immune System—IL6—asthma	1.36e-06	7.53e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—MMP9—asthma	1.35e-06	7.46e-06	CbGpPWpGaD
Nilotinib—LCK—Disease—EGFR—asthma	1.35e-06	7.45e-06	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—PTEN—asthma	1.34e-06	7.43e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—PTEN—asthma	1.34e-06	7.42e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—TGFB1—asthma	1.33e-06	7.36e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—VEGFA—asthma	1.31e-06	7.22e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—EGFR—asthma	1.3e-06	7.21e-06	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—IL6—asthma	1.3e-06	7.17e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—STAT3—asthma	1.29e-06	7.15e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—ALB—asthma	1.29e-06	7.14e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CXCL8—asthma	1.29e-06	7.13e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—IL6—asthma	1.29e-06	7.13e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PPP2CA—asthma	1.28e-06	7.09e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—VEGFA—asthma	1.28e-06	7.07e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PPP2CA—asthma	1.27e-06	7.03e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—STAT3—asthma	1.27e-06	7e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—NOS3—asthma	1.24e-06	6.83e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—IL2—asthma	1.23e-06	6.82e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—VEGFA—asthma	1.21e-06	6.7e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—STAT3—asthma	1.2e-06	6.64e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—POMC—asthma	1.2e-06	6.63e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—TGFB1—asthma	1.2e-06	6.63e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—NQO1—asthma	1.19e-06	6.57e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—EGFR—asthma	1.18e-06	6.5e-06	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—IL6—asthma	1.17e-06	6.49e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—TGFB1—asthma	1.17e-06	6.49e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—MMP9—asthma	1.17e-06	6.45e-06	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—IL6—asthma	1.16e-06	6.43e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ADCY2—asthma	1.16e-06	6.43e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—PTEN—asthma	1.16e-06	6.41e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—EGFR—asthma	1.15e-06	6.36e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—PTGS2—asthma	1.13e-06	6.25e-06	CbGpPWpGaD
Nilotinib—LCK—Immune System—IL6—asthma	1.12e-06	6.2e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—TGFB1—asthma	1.11e-06	6.15e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—ALB—asthma	1.09e-06	6.05e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—EGFR—asthma	1.09e-06	6.03e-06	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—IL6—asthma	1.06e-06	5.86e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—VEGFA—asthma	1.05e-06	5.79e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—NOS3—asthma	1.05e-06	5.78e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—POMC—asthma	1.05e-06	5.78e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—STAT3—asthma	1.04e-06	5.74e-06	CbGpPWpGaD
Nilotinib—LCK—Disease—IL6—asthma	1.04e-06	5.72e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—IL6—asthma	1e-06	5.54e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GSTP1—asthma	9.91e-07	5.48e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—PTEN—asthma	9.86e-07	5.45e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—POMC—asthma	9.85e-07	5.44e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—HMOX1—asthma	9.78e-07	5.4e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—POMC—asthma	9.76e-07	5.4e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ITPR1—asthma	9.75e-07	5.39e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CAT—asthma	9.65e-07	5.33e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—TGFB1—asthma	9.62e-07	5.32e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—PTGS2—asthma	9.57e-07	5.29e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—ALB—asthma	9.53e-07	5.27e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—EGFR—asthma	9.43e-07	5.21e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—NOS3—asthma	9.11e-07	5.04e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GSTM1—asthma	9.11e-07	5.04e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PLA2G4A—asthma	9.11e-07	5.04e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—IL6—asthma	9.03e-07	4.99e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—ALB—asthma	8.98e-07	4.96e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—ALB—asthma	8.9e-07	4.92e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—IL6—asthma	8.85e-07	4.89e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—NOS3—asthma	8.59e-07	4.75e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—NOS3—asthma	8.51e-07	4.71e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PPP2CA—asthma	8.39e-07	4.64e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—IL6—asthma	8.38e-07	4.63e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—PTEN—asthma	8.34e-07	4.61e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PTGS2—asthma	8.34e-07	4.61e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PTGS2—asthma	7.85e-07	4.34e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PTGS2—asthma	7.79e-07	4.3e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PTEN—asthma	7.27e-07	4.02e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—IL6—asthma	7.25e-07	4.01e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PTEN—asthma	6.85e-07	3.79e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PTEN—asthma	6.79e-07	3.75e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—POMC—asthma	6.44e-07	3.56e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ALB—asthma	5.87e-07	3.24e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—NOS3—asthma	5.62e-07	3.1e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PTGS2—asthma	5.14e-07	2.84e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PTEN—asthma	4.48e-07	2.48e-06	CbGpPWpGaD
